Léo Laoubi - Concepedia

Author

Léo Laoubi

Université Claude Bernard Lyon 1 ORCID

Also Known As

L. Laoubi, Laoubi, Léo, Laoubi, Léo, Leo LAOUBI, Leo Laoubi, Léo Laoubi

Publications

339

Citations

H-Index

Concepts

All Affiliations

Université Claude Bernard Lyon 1 Centre National de la Recherche Scientifique Centre International de Recherche en Infectiologie Inserm École Normale Supérieure de Lyon

About

Léo Laoubi is an author at Université Claude Bernard Lyon 1 specializing in allergy, medicine, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	112
2	Allergy	2	2	112
3	Immunology	2	2	112
4	Autoimmune Disease	2	2	112
5	Allergy Medicine	1	1	92

Léo Laoubi

Publications

331

Citations

H-Index

Page 1

	Year	Citations
Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy Pia Gamradt, Léo Laoubi, Audrey Nosbaum, Journal of Allergy and Clinical Immunology Autoimmune DiseaseAllergyAllergy MedicineMedicineImmunology	2019	92
<scp>IL</scp>‐1β induces thymic stromal lymphopoietin and an atopic dermatitis‐like phenotype in reconstructed healthy human epidermis Marine Bernard, C. Acuña Carrasco, Léo Laoubi, The Journal of Pathology	2017	58
Topical ivermectin improves allergic skin inflammation Erwan Ventre, Aurore Rozières, Vanina Lenief, Allergy	2017	57
Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice Vincent Dioszeghy, Lucie Mondoulet, Léo Laoubi, Frontiers in Immunology	2018	49
A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells Vijaykumar Patra, Léo Laoubi, Jean‐François Nicolas, Frontiers in Medicine	2018	42
Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets Léo Laoubi, Morgane Lacoffrette, Séverine Valsesia, Journal of Allergy and Clinical Immunology Autoimmune DiseaseAllergyAtopic DermatitisMedicineImmunology	2022	20
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2 Candice Sakref, Alexis Saby, Céline Rodriguez, Nature Communications	2025	13

Page 1